KRTL BioTech

Dismal decade for emerging markets casts pall over repeated 'buy' notes

Dismal decade for emerging markets casts pall over repeated 'buy' notes

One of the hardiest investment fixtures has been the annual 'buy' note on emerging markets equities, but their dismal performance over the past decade begs the question why.